mRNA and plasma levels of cytokines in newly diagnosed and chronic ITP. DNA microarray expression is presented in (A) CX3CR1 (relative expression of newly diagnosed 5765 ± 988 vs chronic 2907 ± 283), (C) IL-16 (relative expression of newly diagnosed 1312 ± 124 vs chronic 812 ± 161), (F) TNF-related weak inducer of apoptosis (TWEAK) (relative expression of newly diagnosed 649 ± 75 vs chronic 397 ± 36), and (H) IL-4 (relative expression of newly diagnosed 16.3 ± 5.8 vs chronic 48.0 ± 6.2). Real-time PCR analysis CX3CR1 is presented in (B) (relative expression of newly diagnosed 0.019 ± 0.0086 vs chronic 0.0050 ± 0.0016). Plasma analysis is presented in (D) IL-16 in the Swedish cohort (relative expression of newly diagnosed 160 ± 18.7 vs chronic 96 ± 11.2), (E) IL-16 in the Chinese cohort (relative expression of newly diagnosed 114 ± 16.6 vs chronic 70 ± 4.2), (G) TWEAK in the Chinese cohort (relative expression of newly diagnosed 881 ± 57.7 vs chronic 632 ± 54.3) and (I) IL-4 in the Chinese cohort (relative expression of newly diagnosed 2.8 ± 0.30 vs chronic 6.4 ± 0.40).